Financial incentives for smoking cessation medication in european countries from the perspective of the angiology outpatient clinics
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F17%3A00099208" target="_blank" >RIV/00216224:14310/17:00099208 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Financial incentives for smoking cessation medication in european countries from the perspective of the angiology outpatient clinics
Original language description
There is a large disproportion in the access to the smoking cessation medication across European countries, with lower financial support in the eastern and central Europe. Majority of the European population suffers of limited access to the medication used for smoking cessation due to limited or no financial coverage by their health insurance companies. This gap is even bigger by restricted support for the prescriptions by vascular and other specialists.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů